Related by context. All words. (Click for frequent words.) 77 analyst Jim Reddoch 70 Joel Sendek 67 Joshua Schimmer 66 analyst Jonathan Aschoff 66 Dr. Jim Birchenough 65 Bret Holley 65 analyst Jim Birchenough 65 Eric Ende 64 Jason Gurda 64 Joseph Pantginis 64 analyst Cory Kasimov 64 Yaron Werber 64 Akhtar Samad 64 Geoffrey Porges 63 Andrew Vaino 63 James Kumpel 63 Dr. Joshua Schimmer 63 Roopesh Patel 63 Geoff Porges 63 Jason Kantor 62 analyst Yaron Werber 62 Jason Kolbert 62 Geoffrey Meacham 62 Bert Hazlett 62 David Amsellem 62 Jami Rubin 62 Gbola Amusa 62 analyst Simos Simeonidis 61 Affymax AFFY 61 Geoff Meacham 61 Annabel Samimy 61 Vertex VRTX 61 analyst Amit Hazan 61 analyst Jami Rubin 61 Jim Birchenough 60 analyst Sapna Srivastava 60 Merck boceprevir 60 Liisa Bayko 60 analyst Geoffrey Meacham 60 analyst Mark Schoenebaum 60 analyst Glenn Novarro 60 analyst Elemer Piros 60 analyst Mark Monane 60 Ken Cacciatore 60 analyst Randall Stanicky 59 Ian Somaiya 59 Elan Tysabri 59 analyst Maged Shenouda 59 analyst Seamus Fernandez 59 Jon LeCroy 59 Piper Jaffray PJC 59 Jonathan Aschoff 59 Sam Fazeli 59 Kochnover 59 Mark Monane 59 Steven Harr 59 Olav Zilian 59 Dr. Yaron Werber 59 Eric Coldwell 59 Kin Ho 59 Bruce Cranna 58 analyst Mehdi Hosseini 58 Chris Shibutani 58 analyst Gbola Amusa 58 analyst Bruce Nudell 58 Andreas Theisen 58 United Therapeutics UTHR 58 analyst Geoffrey Porges 58 Scott Geels 58 Sara Michelmore 58 Edward Tenthoff 58 Mark Schoenebaum 58 Phil Nalbone 58 Gilead Sciences nasdaq GILD 58 analyst George Grofik 58 Seamus Fernandez 57 analyst Ken Trbovich 57 Larry Biegelsen 57 Vertex hepatitis C 57 Jerry Doctrow 57 Trevor Polischuk 57 Daniel Berenbaum 57 analyst Bijan Moazami 57 reaffirmed Outperform rating 57 Bruce Nudell 57 Amylin Byetta 57 analyst Rommel Dionisio 57 Inc. NASDAQ ITMN 57 reaffirmed Market Perform 57 analyst Robert Cihra 57 Gilead GILD 57 analyst Randy Binner 56 Monane 56 Amylin Eli Lilly 56 Amylin AMLN 56 analyst Larry Biegelsen 56 analyst Lawrence Keusch 56 Cory Kasimov 56 Sepracor SEPR 56 Seattle Genetics SGEN 56 analyst Hari Sambasivam 56 Celgene Revlimid 56 TSRX 56 Liana Moussatos 56 Eitan Bernstein 56 David Hochstim 56 analyst Alan Bezoza 56 Alexandra Hauber 56 Jeffrey Holford 56 Molowa 56 Thomas R. Wadewitz 55 analyst Alex Gauna 55 Douglas Harned 55 Randall Stanicky 55 Mark Bacurin 55 Cubist Pharma 55 Dendreon Provenge 55 Reik Read 55 Dificid 55 Onyx Pharma 55 Ronny Gal 55 Analyst Toni Sacconaghi 55 Jon Lecroy 55 analyst Jacques Rousseau 55 Amgen Prolia 55 analyst Tore Svanberg 55 Dhulsini de Zoysa 55 Moussatos 55 Chris Brendler 55 Betsy Van Hees 55 analyst Steven Wieczynski 55 Ulrich Huwald 54 Mike Krensavage 54 Luke Folta 54 Pantginis 54 Darren Lehrich 54 analyst Joanne Wuensch 54 Carl Christensen XPRESSTRADE 54 Tad Piper 54 Saftlas 54 Amgen denosumab 54 BioMedTracker 54 Funtleyder 54 Vertex telaprevir 54 midstage clinical 54 Rachael Rothman 54 AMAG Pharma 54 Jeff Wlodarczak 54 ONXX 54 Robert Lacoursiere 54 Maintains Neutral 54 Forest Labs FRX 54 analyst Randal Konik 54 analyst Bruce Cranna 54 Curagen 54 Scott Snyder XPRESSTRADE 54 Amylin Pharmaceuticals Nasdaq AMLN 54 John Calcagnini 54 Byetta LAR 54 Navdeep Jaikaria 54 drug Treanda 54 generic Lovenox 53 Celgene NASDAQ CELG 53 BIOTECH STOCKS Drug 53 Deane Dray 53 Ahmar Zaman 53 analyst Constance Maneaty 53 Novartis Gilenia 53 Navid Malik 53 ImClone Erbitux 53 George Staphos 53 Simos Simeonidis 53 Millennium Velcade 53 Jeffrey Frelick 53 analyst Patrick Walravens 53 analyst Dara Mohsenian 53 Maintains Hold 53 Justin Hott 53 Medivation Inc 53 Ken Trbovich 53 analyst Jeff Fidacaro 53 Reiterates Hold 53 NASDAQ ONXX 53 Allos Therapeutics Incorporated 53 Glaxo Relenza 53 Ziopharm 53 analyst Liana Moussatos 53 James Janesky 53 Velcade bortezomib 53 F3Q 53 F2Q EPS 53 Volterra Semi 53 Tenthoff 53 Donald Fandetti 53 analsyts 53 Raj Denhoy 53 Plovanic 53 Savvas Neophytou 53 analyst Pablo Zuanic 53 Matt Miksic 53 Randal Konik 53 motesanib 53 Hamed Khorsand 53 April Scee 53 analyst Alexandra Hauber 53 Reiterates Buy rating 53 George Grofik 53 analyst Charles Boorady 52 Scott Mushkin 52 D mab 52 Damien Conover 52 Stanicky 52 Kemp Dolliver 52 Glenn Novarro 52 analyst Glenn Reicin 52 NASDAQ ACOR 52 Charles Boorady 52 analyst Kristine Koerber 52 Ken Zerbe 52 MyVax 52 Suji De Silva 52 Schoenebaum 52 analyst Ananda Baruah 52 exenatide LAR 52 analyst Mark Edelstone 52 drug figitumumab 52 Amgen Vectibix 52 Holger Blum 52 Oncogenex 52 Zocor Zetia 52 IG HCR ;) CO 52 Andrew Obin 52 analyst Bruce Harting 52 Analyst Rebecca Arbogast 52 BernsteinResearch 52 Steven Alexopoulos 52 Gary Nachman 52 analyst Mark Lipacis 52 analyst Junaid Husain 52 Recentin 52 William Tanona 52 Glenn Reicin 52 Maintains Buy 52 Romit Shah 52 Chiron CHIR 52 analyst Emme Kozloff 52 Mahesh Sanganeria 52 reaffirmed Neutral 52 Novartis Prexige 52 WR Hambrecht reiterate 52 Cantor Fitzgerald reiterates 52 Andy Kaplowitz 52 Grofik 52 Stacy Rasgon 52 Mark Urness 52 analyst Louis Miscioscia 52 analyst Brad Hintz 52 Kevin Scotcher 52 Maher Yaghi 52 Tao Levy 52 analyst Gurinder Kalra 52 Phil Skolnick 52 MRK.N 52 Lauren Cooks Levitan 52 economist Tushar Poddar 52 Isaac Ro 52 Martin Possienke 52 Claude Camire 52 Nik Modi 52 Leerink Swan 52 Mark Astrachan 52 Rajesh Ghai 52 Patrick Walravens 52 analyst Raj Denhoy 52 James Manuso 52 analyst Mahesh Sanganeria 52 Ari Charney Portfolio 52 Sumit Dhanda 52 Dr. McHutchison 52 Jeremy Sussman 52 Carsten Kunold 51 Glen Yeung 51 analyst Tim Savageaux 51 Rob Cihra 51 analyst Ajit Pai 51 Karl Heinz Koch 51 spokeswoman Lenore Gelb 51 Nicholas Aberle 51 Reddoch 51 Adventrx 51 analyst Ross Muken 51 Kevin Ellich 51 Raises PT 51 Kenneth Zaslow 51 Claudia Shank Hueston 51 John DiFucci 51 Roche Actemra 51 analyst Amit Daryanani 51 Richfield Minn. retailer 51 Vishal Shreedhar 51 Reiterate Outperform rating 51 Bristol Myers NYSE BMY 51 Surajit Pal 51 Helene Wolk 51 Tristan Gerra 51 Allan Monks 51 analyst Andrey Glukhov 51 Pfizer inhaled insulin 51 Friedman Billings 51 Reiterates Outperform 51 Idenix Pharmaceuticals 51 analyst Shebly Seyrafi 51 Adrienne Tennant 51 Viropharma 51 Mark G. Foletta 51 Safi Bahcall Ph.D. 51 Matt Nemer 51 Novo Nordisk NOVOb.CO 51 analyst Frank Mitsch 51 Taranabant 51 Maintains Overweight 51 authority Gurian Sherman 51 Jon Langenfeld 51 Srini Pajjuri 51 Analyst Cody Acree 51 analyst Tristan Gerra 51 Piper Jaffray downgraded 51 analyst Mark Wienkes 51 analyst Koya Tabata 51 Steven Wieczynski 51 Groschke 51 Andrew Speller 51 Camvia 51 Geoff Ruddell 51 David Molowa 51 Ananda Baruah 51 Paul Cuddon 51 Co reaffirms FY# 51 analyst Edward Yruma 51 FBR Capital Upgrades 51 earnigns 51 Advate 51 analyst Uche Orji 51 Avastin Herceptin 51 Tom Cholnoky 51 Karl Heinz Scheunemann 51 analyst Robert Koort 51 Scott Krasik 51 Sackner Bernstein 51 Ajit Pai 51 AstraZeneca AZN.ISE 51 Carl Seiden 51 Robert Spingarn 51 Revlimid 51 Andrew Kligerman 51 Luuk van Beek 51 Optimer Pharmaceuticals 50 Mabthera 50 Matt DiFrisco 50 Preos 50 analyst Victor Bareno 50 pulls Darvon painkiller 50 Vitaxin 50 Helvea analyst Olav Zilian 50 Reiterates Hold Rating 50 Michael Masdea 50 Ana Gupte 50 Kristine Koerber 50 Merck Januvia 50 Birgit Kulhoff 50 Reiterates Neutral Rating 50 analyst Irene Nattel 50 Xenoport Inc. 50 generic Copaxone 50 Krishna Shankar 50 Sven Jari Stehn 50 Isis Pharma 50 Dr. Emilio Emini 50 Tesofensine 50 Lilly Amylin 50 Maintains Buy rating 50 Foradil Serevent 50 Michael Bruynesteyn 50 Canaccord Genuity Maintains Hold 50 Randy Binner 50 Eric Siemers 50 analyst Ana Gupte 50 Todd Bault 50 Financial XLF Bearish 50 Co. nyse LLY 50 Amevive 50 Timothy Arcuri 50 drug anacetrapib 50 Arcalyst 50 Y. Edwin Mok 50 Robert Breza 50 Suresh Balaraman 50 BioMarin Pharma 50 OGXI 50 analyst Heather Bellini 50 Fablyn 50 Matthew Borsch 50 Paul Mansky 50 Ariad Pharmaceuticals 50 Todd Raker 50 Louis Miscioscia 50 Ricky Goldwasser 50 Joshua Shanker 50 Analysts Initiate Coverage 50 Atherogenics 50 Resumes Coverage 50 Pegintron 50 Susan Katzke 50 Peng Yunliang Shanghai 50 Inc CYBX 50 Auxilium Pharma 50 BWS Financial 50 Singulair asthma 50 analyst Albert Savastano 50 spokeswoman Mariann Caprino 50 Ramon Llamas IDC 50 Nasdaq SLXP 50 Rating Reiterated 50 Nitsan Hargil 50 Jean Pierre Lehner 50 Peter Appert 50 Folotyn 50 Inc. NASDAQ EVVV 50 Michael Linenberg 50 Roche Mircera 50 AstraZeneca AZN.L 行情 50 analyst Bill Pecoriello 50 GSK Avandia 50 Co. LLY.N 50 Panagiotis Spiliopoulos 50 Badishkanian 50 analyst Katherine Styponias 50 analyst Sanjay Sakhrani 50 Chris Umiastowski 50 analyst Donald Fandetti 50 Satya Chillara 50 Nasdaq IDIX 50 Edwin Hemwall 50 Rating Flashback 50 MER.N 50 Remi Barbier 50 Fusilev 50 Craig Siegenthaler 50 GILD GILD 50 Timna Tanners 50 Biogen IDEC 50 Ross Seymore 50 Alain Karaoglan 50 UBS Maintains Neutral 50 analyst Hamed Khorsand 50 Quynh Pham 50 Herman Saftlas 50 analyst Aldo Mazzaferro 50 fampridine SR 50 Edwards Lifesciences EW 50 volatility Elevated 50 Perrigo PRGO 50 grwoth 50 Krystexxa 50 analyst Robert Drbul 50 analyst Vivek Juneja 50 David Dropsey 50 Tony Shiret 50 S. Gajrawala 50 analyst Antony Broadbent 50 Gene Munster Piper Jaffray 50 Dmitry Silversteyn 50 Charlie Di Bona 50 Angelo Airaghi Guest 50 Leerink 50 Charles DiBona 50 Thomas Cholnoky 50 Joseph Amaturo 50 Keeps Neutral 49 Matus contends 49 analyst Srini Pajjuri 49 Co LLY.N 49 Jeff Omohundro 49 Shaojing Tong 49 Satya Kumar 49 Michael Krensavage 49 Nasdaq AVNR 49 Analyst Cai von 49 F3Q EPS 49 Joel Fishbein 49 analyst Jeffrey Zekauskas 49 analyst Alexia Quadrani 49 Kenneth Muth 49 analyst Jason Napodano 49 brokerage Numis 49 analyst Michael Bruynesteyn 49 CE Unterberg 49 analyst Rebecca Runkle 49 William F. Tanona 49 Wells Fargo Initiates Coverage 49 Joseph Foresi 49 analyst Christopher Growe 49 Medicis Pharma 49 analyst Daniel Renouard 49 Broker Numis Securities 49 Novo Nordisk Victoza 49 Rating Maintained 49 experimental lupus 49 analyst Maynard Um 49 analyst Thilo Wrede 49 SVB Financial SIVB 49 analyst Jonathan Schildkraut 49 VRTX 49 Tejas Doshi head 49 Stefan Graber 49 analyst Tony Wible 49 Tee Sze Chiah 49 analyst William Pecoriello 49 Jesse Tortora 49 Jefferies JEF 49 UBS analyst Gbola 49 analyst Ashwin Shirvaikar 49 NASDAQ ANDS 49 William Pecoriello 49 F1Q EPS 49 Zadaxin 49 Assumes Coverage 49 analyst Kian Abouhossein 49 Gary Giblen 49 analyst Amit Bhalla 49 F4Q EPS 49 David Begleiter 49 Jesse Pichel 49 Sam Buttrick 49 Pharma cos 49 Robert Koort 49 Wedbush Maintains 49 analyst Kirk Materne 49 Sena Lund 49 analyst Moshe Orenbuch 49 Hans Joachim Lohrisch 49 Jonathan Golub 49 analyst Peter Misek 49 Stephen Dashevsky 49 SGP.N Quote Profile Research 49 Suntrust Robinson Humphrey 49 David Bleustein 49 Daniel Meron 49 analyst Mario Mendonca 49 Analyst Tristan Gerra 49 Ian de Verteuil 49 Celgene Corp. 49 Vertex Pharmaceuticals NASDAQ VRTX 49 analyst Ivy Zelman 49 analyst Navid Malik 49 Genentech Herceptin 49 Dorothy Lakner 49 analyst Gregory Melich 49 Sven Kuerten 49 Biegelsen 49 Matthew DiFrisco 49 analyst Loren Loverde 49 Drew Brosseau 49 Jeff Klinefelter 49 Dominic Valder 49 analyst Robert Campagnino 49 Rhyee 49 Schering Plough NYSE SGP 49 Alex Rygiel 49 Drew Matus economist 49 Daniel Fannon 49 OTC Claritin 49 Vijay Rakesh 49 analyst Sal Tharani 49 Carrols Restaurant 49 downwardly revise 49 Intermune 49 RBC Capital Mkts Reiterate 49 Cai von Rumohr 49 Rainer Guntermann 49 Roland Haefeli 49 analyst Greg Badishkanian 49 analyst Elizabeth Osur 49 Matthew Heimermann 49 Michael Shillaker 49 UCB Keppra 49 muscle relaxant Amrix 49 NASDAQ ARIA 49 Texas Roadhouse TXRH 49 analyst Laura Champine 49 Xenoport 49 Ton Gietman 49 Gerry Hennigan 49 Keay Nakae 49 3Q Profit Doubles 49 analyst Rick Sherlund 49 analyst Dinesh Moorjani 49 PiperJaffray 49 NASDAQ FBCM 49 analyst Maher Yaghi 49 analyst Alexander Peterc 49 Colazal 49 Michael Turits 49 analyst Margaret Mager 49 Panzem 49 Treanda 49 analyst Charles Grom 49 Armando Anido 49 anticholesterol 49 JMP Securities downgraded 49 Co. analyst Shebly 49 Rehaut 48 HIV treatments Reyataz 48 Craig Kennison 48 Maintains Outperform 48 Robert Cihra 48 analyst Phillip Nalbone 48 Manoj Garg 48 Maintain Neutral 48 analyst Gregory Badishkanian 48 Edwin Groshans 48 Reiterate Buy rating 48 Aaron Reames 48 analyst Richard Repetto 48 BioCentury NewsMakers 48 Marc Cluzel 48 analyst Anthony Chukumba 48 Fourth Quarter Earnings Preview 48 CAMPATH 48 Anurag Rana 48 Tobias Levkovich 48 Carla Antunes da Silva 48 Lawrence Biegelsen 48 Lowers PT 48 Lisnic 48 Andrew Parmentier 48 Janet Brashear 48 Rod Bourgeois 48 Punk Ziegel 48 spokeswoman Christine Fanelle 48 Timothy Conder 48 Kotak Institutional Equities 48 FQ1 48 Co. MRK.N 48 Gets Downgraded 48 NASDAQ ALXN 48 John F. Thero 48 hypertension drugs Cozaar 48 Lawrence Keusch 48 Navigant Consulting Inc 48 Marc Eiger 48 analyst Chad Friess 48 Conscius Capital Partners 48 Barrie Cornes 48 analyst William Tanona 48 Nick Levidy 48 Industrial XLI Bearish 48 reports Q4 adj 48 Sal Tharani 48 Nigel Dally 48 Susan Roth Katzke 48 Abbott Niaspan 48 analyst Benjamin Reitzes 48 Brion Tanous 48 Robyn Karnauskas 48 Shire LSE SHP 48 Constantine Davides 48 STOCKS Futures slip 48 Dr. Gail Cawkwell 48 Luminex NASDAQ LMNX 48 Margaret Mager 48 Lazard Capital 48 Zuanic 48 McKesson MCK 48 Sterling Auty 48 uh ruh 48 Christopher Danely 48 analyst Annabel Samimy 48 Sipkin 48 GE Omar Ishrak 48 Insmed Incorporated NASDAQ INSM 48 John Kartsonas 48 analyst Brad Reback 48 Denhoy 48 analyst Michael Rehaut 48 Humira arthritis 48 Nasdaq IPXL 48 Morten Singleton 48 ThinkEquity downgraded 48 Tahira Afzal 48 analyst Kimberly Greenberger 48 F#Q# revenues 48 analyst Julio Quinteros 48 Maintain Buy 48 Jed Dorsheimer 48 Carlos Laboy 48 JoAnne Feeney 48 WBB Securities LLC 48 Brett Hoselton 48 Analyst Gene Munster 48 Nathan Schneiderman 48 analyst Matthew Fassler 48 Tore Svanberg 48 analyst Anna Torma 48 analyst Curtis Shauger 48 Submits Response 48 analyst Sasa Zorovic 48 Hulk Caris & 48 Barclays Capital Reiterate Overweight 48 Jonathan Ruykhaver 48 Mark Kalinowski 48 Micrel MCRL 48 RBC Capital NYSE RY 48 Daniel Oppenheim 48 FQ2 EPS 48 Joshua Raskin 48 FBR Capital Maintains 48 Technology XLK Bearish 48 Biogen multiple sclerosis 48 UCB Cimzia 48 Immunogen 48 Varian Semi 48 Pargluva 48 analyst Mark Swartzberg 48 DepoMed 48 analyst Richard Fetyko 48 RAPTIVA r 48 Dr. LaMattina 48 NASDAQ ADLR 48 Virginia Genereux 48 Kalpesh Kapadia 48 Stelios Papadopoulos 48 Zybrestat 48 Small Cap Institutional Investor 48 Amsurg NASDAQ AMSG 48 analyst Doug Leggate 48 Apurva Shah head 48 Orville Kolterman 48 F2Q 48 Piper Jaffray Maintains 48 strategist Teun Draaisma 48 Sanjiv Wadhwani 48 Genentech Raptiva 48 Peter Rozenberg 48 ENSCO PLC 48 analyst Joseph Altobello 48 Cantor Fitzgerald reiterate 48 F#Q# EPS ahead 48 Kash Rangan 48 analyst Onno Rutten 48 Todd Duvick 48 Edgar Roesch 48 analyst George Staphos 48 Brean Murray downgrades 48 Kurt Hallead 48 analyst Hussein Allidina 48 eczema creams 48 Jochen Rothenbacher 48 Degludec 48 Lee Klaskow 48 Cazenove downgraded 48 analyst Chris Woronka 48 Vioxx Zocor 48 analyst Eric Beder 48 Vectical TM Ointment 48 Thom Gunderson 48 analyst Rob Rutschow 48 Bruce Harting 48 analyst Gus Papageorgiou 48 darbepoetin alpha 48 analyst Safa Rashtchy 48 Orbimed Advisors LLC 48 Douglas Anmuth 48 Matthew Emmens 48 containing abacavir 48 analyst Ambrish Srivastava 48 ViroPharma Nasdaq VPHM 48 Zekauskas 48 Sydbank analyst Rune Dahl 48 Nexium ulcer medicine 48 Reiterate Buy 48 RESEARCH ALERT Prudential 48 Anthony Gikas 48 analyst Mitch Kummetz 48 Simponi golimumab 48 Corlux 48 FQ2 48 spokesman Tony Plohoros 48 Charles Minervino 48 Joe Osha 48 Mark Edelstone 47 Roger Perlmutter Amgen 47 Switzerland Serono SA 47 midstage clinical testing 47 Energy XLE Bearish 47 Kosin Sripaiboon 47 Myriad Genetics Nasdaq MYGN 47 Company Report companiesandmarkets.com 47 Swiss brokerage Helvea 47 Adam Barkstrom managing 47 F1Q 47 FQ4 EPS 47 analyst Ehud Gelblum 47 Kathryn Huberty 47 Ivy Zelman 47 Synovus Financial SNV 47 Sentiment Snapshot 47 Maintains Market Perform 47 Antegren 47 Gregory Drahuschak 47 Biogen Nasdaq BIIB 47 analyst Des Kilalea 47 Dr. Pazdur 47 upwardly revise 47 NEUTRAL rating 47 Brad Reback 47 Ron Bentsur 47 David Janazzo 47 Ingrid Ebeling 47 Huang Xiangbin 47 ImmunoGen IMGN 47 Emme Kozloff 47 Co MRK 47 Tanona 47 Cepheid NASDAQ CPHD 47 means optimists outnumber 47 marketperformer 47 Michael Vinciquerra 47 Itay Michaeli 47 analyst Joshua Shanker 47 SME Direkt survey 47 analyst Brent Thill 47 vorapaxar 47 analyst Deane Dray 47 Visiongain predicts 47 analyst Connie Maneaty 47 analyst Youssef Squali 47 Steven Halper 47 Sav Neophytou 47 analyst Katy Huberty 47 analyst Dan Wantrobski 47 CR Bard BCR 47 strategist Makoto Yamashita 47 Christine Farkas 47 instrument SHORT TERM 47 #.#.# Amulya Ganguli 47 TREASURIES Prices fall 47 analyst Edwin Mok 47 SME Direkt poll 47 Merck MRK Pfizer PFE 47 Pat Walravens 47 lowers FY# EPS 47 Rajiv Gulati 47 ThinkPanmure 47 Matthew Fassler 47 BoA ML 47 Matthew Kather 47 Exanta 47 Ben Mogil 47 NASDAQ GPRO 47 Ryland Presentation 47 GlaxoSmithKline Plc diabetes 47 Eli Lilly LLY 47 inhibit KSP 47 analyst Toni Sacconaghi 47 Maintains outperform 47 Atsushi Seki 47 Drew Fromkin President 47 Cameron Doerksen Versant Partners 47 Pablo Zuanic 47 Polymeropoulos 47 Maintains Outperform Rating 47 Alnylam Nasdaq ALNY 47 Underweight rating 47 reports Q3 adj 47 Rule Breakers pick 47 Dylan Cathers 47 Janardan Menon 47 Johan Eliason 47 Richard Kugele 47 Gudme Raaschou 47 Stifel Nicolaus downgraded 47 FBR Capital NASDAQ FBCM 47 analyst Ghansham Panjabi 47 Stephen Volkmann 47 Theo Kitz 47 Zyprexa Cymbalta 47 Jonathan Dorsheimer 47 Oliver Gilvarry 47 George Toriola 47 analyst Michael Exstein 47 analyst Jefferson Harralson 47 FQ3 47 Analyst Craig Moffett 47 Broker Panmure Gordon 47 Georg Marti 47 Martin Schwerdtfeger 47 analyst Tim Klasell 47 Sherri Scribner 47 Phase III LibiGel 47 Hakan Edstrom 47 Harry Palmin President 47 Canaccord Adams Hepatitis C 47 Reiterates Buy 47 Bresalier 47 Moshe Katri 47 analyst Peter Nesvold 47 Satoru Ogasawara strategist 47 analyst Michael Masdea 47 Inc Therapeutic Competitors 47 UBS Maintains Buy 47 analyst Robyn Karnauskas 47 Clyde Montevirgen 47 Lars Kjellberg 47 Patent expiries 47 Leerink analyst 47 analyst Dorothy Lakner 47 Puts Sold 47 ABX EGF 47 James McIlree 47 economist Joseph LaVorgna 47 economist Ted Wieseman 47 Sector Outperform 47 maker Barr Pharmaceuticals 47 Darusentan 47 Slashes FY# 47 analyst Colin McGranahan 47 Nicholas Landekic 47 Jefferies NYSE JEF 47 Sector Outperformer 47 Mark A. Sirgo 47 Joseph LaVorgna Deutsche 47 Piper Jaffray reiterate 47 Drew Matus 47 IV bisphosphonates 47 Wensheng Peng 47 Sara Elford 47 John Janedis 47 Christa Quarles 47 Steven Brozak 47 analystsâ € ™ 47 Jason Napodano 47 analyst Inder Singh 47 Canaccord Genuity Reiterates Buy 47 Pantry NASDAQ PTRY 47 analyst Moshe Katri 47 ANALYST TAKE Analysts 47 Steven Winoker 47 OTC Mevacor 47 Finncap 47 analyst Adrienne Tennant 47 Urban Outfitters NASDAQ URBN 47 Friedman Billings Ramsay 47 Uta Werner 47 Canvaxin 47 Standpoint Research downgraded 47 Chief Executive Matthew Emmens 47 Tony Clapsis 47 Taxus drug eluting 47 Kaumil Gajrawala 47 Meteorologist Kevin Skarupa 47 Manus Costello 47 analyst Matt Snowling 47 Rommel Dionisio 47 analyst Dan Geiman 47 RESEARCH ALERT Lehman 46 downwardly adjusted 46 Ladenburg Thalmann analyst 46 analyst Lizabeth Dunn 46 analyst Timna Tanners 46 William Plovanic 46 Competitive Benchmarking Product 46 Nuedexta 46 analyst Romit Shah 46 Fairly Valued stance 46 R. Scott Siefers 46 Noven Pharmaceuticals NOVN 46 Daniele Antonucci 46 Georges Gemayel 46 Steven Kron 46 undemanding valuations 46 Abbott ABT 46 damped optimism 46 Michael Taiano 46 John Heinbockel 46 Richard Fetyko 46 COWN 46 spokeswoman Caroline Pecquet 46 ThinkEquity upgraded 46 LyondellBasell Industries NYSE LYB 46 PMC Sierra PMCS 46 Second Quarter Earnings Preview 46 Maintains FY# 46 Citi Initiates Coverage 46 economist Dermot O'Leary 46 Jay Gelb 46 J. Steven Smigie 46 Citi Maintains Buy 46 Cameron Kusher